Critically analyse WHO's concerns regarding youth-targeted marketing of nicotine products and India's policy response.

Nicotine pouches — tobacco-free sachets placed between lip and gum — have turned marketing, not combustion, into the frontier of tobacco control. With global retail sales crossing 23 billion units in 2024, up over 50% in a year [1], WHO's 2026 warning is timely; India's response is proactive in parts, but incomplete.

WHO's concerns: the architecture of appeal

• Marketing design: sleek, discreet packaging, fruit and bubble-gum flavours, some packs mimicking candy brands — engineered for first-time young users [1].
• New promotion channels: social media influencers and sponsorship of mass-youth events such as Formula 1, bypassing conventional advertising bans [1].
• Health basis: nicotine harms the developing adolescent brain and raises cardiovascular risk; industry "reinvents its business model" around such products [2].
• Regulatory vacuum: roughly 160 countries have no specific rules on pouches; only 32 regulate and 16 ban them [1].

India's response: strengths

• Pre-emptive prohibition: the Prohibition of Electronic Cigarettes Act, 2019 banned production, sale, storage and advertisement of ENDS, explicitly to shield youth from addiction [3].
• Statutory base: COTPA, 2003 restricts advertisement, sale to minors and packaging of tobacco products [5]; food safety regulations bar nicotine as a food ingredient.
• New-media regulation: 2023 guidelines extended anti-tobacco warnings to OTT curated content [4], recognising digital promotion.

Critical gaps

• Definitional: pouches contain nicotine but no tobacco, so COTPA's "tobacco products" definition arguably does not reach them — and restrictions on trade under Article 19(1)(g) are strictly construed.
• Classificatory confusion: food, drug or tobacco product remains unsettled, leaving import and duty-free sale ambiguous.
• Enforcement: supply through e-commerce, hookah outlets and gig-delivery apps outruns state-level tobacco enforcement machinery.

India's framework is thus strong on devices but weak on molecules. Shifting statutory language from "tobacco" to "nicotine products", plus flavour and influencer-marketing curbs as WHO recommends [2], would align domestic law with FCTC commitments and protect the demographic dividend.